Skip to content

Nasisoft Forte 3 Hyal

by Diaco Biofarmaceutici srl Italy EUDAMED

Ref 6088Model sterile solution for inhalation and intranasal administration 3% ( 30 gr/ml sodium chloride, 1 mg/ml sodium hyaluronate)

EMDN Q030103

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-6088BH Basic UDI-DIDate8 Oct 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Nasisoft Forte 3 Hyal
Model / Reference
sterile solution for inhalation and intranasal administration 3% ( 30 gr/ml sodium chloride, 1 mg/ml sodium hyaluronate), 6088
Primary DI / UDI-DI
D-6088BH
Basic UDI-DI
B-6088BH
EMDN Code
Q030103 Nasal irrigation solutions
Device Class
Class IIa
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000012117

From the manufacturer

Manufacturer's product page: Nasisoft Forte 3 hyal

Other devices from Diaco Biofarmaceutici srl

See all devices from Diaco Biofarmaceutici srl →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
Other properties (10)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED D-6088BH|B-6088BH 61 fields · synced 24 Oct 2026